BNP Paribas’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.36M Sell
102,139
-1,125
-1% -$98.4K 0.25% 69
2026
Q1
$8.8M Buy
103,264
+99,881
+2,952% +$8.9M 0.28% 66
2025
Q4
$369K Sell
3,383
-89,127
-96% -$6.99M 0.01% 220
2025
Q3
$7.5M Buy
92,510
+10,485
+13% +$894K 0.23% 75
2025
Q2
$7.46M Buy
82,025
+11,408
+16% +$1.04M 0.24% 77
2025
Q1
$6.62M Buy
70,617
+70,352
+26,548% +$6.3M 0.27% 78
2024
Q4
$5.84M Hold
265
0.03% 79
2024
Q3
$27.5K Sell
265
-85
-24% -$8.66K ﹤0.01% 289
2024
Q2
$34K Sell
350
-84,751
-100% -$7.82M ﹤0.01% 263
2024
Q1
$7.66M Buy
+85,101
New +$7.21M 0.36% 62

Other funds holding CL

BNP Paribas's CL Position: Q2 2026 in Review

BNP Paribas reduced its Colgate-Palmolive (CL) stake by 1.1% in Q2 2026, selling an estimated $98.4K and leaving 102,139 shares worth $9.36M. The position accounts for 0.25% of the portfolio, ranked #69.

BNP Paribas first reported a position in CL in Q1 2024 and has held it in 10 quarters since. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • BNP Paribas held 102,139 shares of Colgate-Palmolive worth $9.36M as of Q2 2026.
  • BNP Paribas sold 1,125 Colgate-Palmolive shares in Q2 2026, an estimated $98.4K.
  • Colgate-Palmolive made up 0.25% of BNP Paribas's portfolio in Q2 2026, its #69 holding.
  • BNP Paribas first reported a position in Colgate-Palmolive in Q1 2024 and has held it in 10 quarters since.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.